WuXi Bio Slumps on Geopolitical Concerns After US Draft Bill

(Bloomberg) -- WuXi Biologics Cayman Inc. shares slumped for the second day as investors worried over a ramp-up in geopolitical tensions following a US draft bill targeting Chinese biotech companies.Most Read from BloombergTraders Line Up for ‘Once-in-a-Generation’ Emerging Markets BetSingapore’s $200,000 Toyotas Fuel Angst Over Wealth GapHouthi Hit on Russian Fuel Has Traders Recalculating RisksThree US Troops Killed in Attack Tied to Iran-Backed GroupsTrump’s Cash Stockpile at Risk From $450 M

Related Keywords

United States ,Washington ,China ,Switzerland ,Wuxi ,Jiangsu ,Beijing ,Hong Kong ,Swiss ,Chinese ,American ,John Cheng ,Jialin Zhang ,Donald Trump ,Helen Sun ,Zhisheng Chen ,Bloomberg Businessweek ,Wuxi Apptec Co ,Bloomberg Wuxi Biologics Cayman Inc ,Bloomberg ,Academy Of Military Medical Sciences ,Korea Samsung Biologics Co ,Nomura International Hk Ltd ,Lonza Group ,Hong Kong Monday ,Chief Executive Officer Zhisheng Chen ,Military Medical Sciences ,Wuxi Biologics ,Communist Party ,Nomura International ,Wuxi Apptec ,South Korea ,Samsung Biologics ,Chinese Biotech Companies ,Geopolitical Tensions ,